Mon.Sep 02, 2024

article thumbnail

U.K.’s Cost-Effectiveness Watchdog NICE Says No To Alzheimer’s Drug Leqembi

Forbes Healthcare

The U.K. regulatory authority approved the Alzheimer's disease drug, Leqembi, last month. But the U.K. cost-effectiveness watchdog NICE recommends against reimbursement.

288
288
article thumbnail

33% of Nurses Quit in First Two Years

Scrubs

Nursing is one of the hardest jobs in the country, and the first few years can be a wake-up call to aspiring providers trying to find their place in the healthcare industry. Many new nurses quickly realize that nursing isn’t for them, while others wind up in jobs that make them want to quit. Studies show 33% of new nurses leave the workforce within the first two years largely due to poor work-life balance, unsafe working conditions, and the emotional strain that comes with caring for patients a

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The aging nursing population is contributing to the U.S. nursing shortage

KevinMD.com

The aging nursing population is one of the underlying conditions contributing to the nursing shortage in the United States. According to the U.S. Chamber of Commerce, 1 million nurses are at least 50 years of age, and 60 percent of nurses are over age 40. Furthermore, over 20 percent of nurses plan to retire within Read more… The aging nursing population is contributing to the U.S. nursing shortage originally appeared in KevinMD.com.

114
114
article thumbnail

Should Nurses Try to Get Published?

Minority Nurse

When we think about nurses getting published, our thoughts naturally turn to nurses in academia doing research or teaching. However, being published is actually for everyone. Any nurse has the opportunity to be published, which can open the doors of possibility and reveal unforeseen career opportunities. Why Get Published? Dottie Roberts, EdD, MSN, MACI, RN, OCNS-C, CMSRN, CNE, has been the editor of the MEDSURG Nursing journal since 2002 and sees getting published as an equal opportunity. 

article thumbnail

How to Start Virtual Care the Right Way: A Proven Roadmap for 2025 and Beyond

Speaker: Dr. Christine Gall, DrPH, MS, BSN, RN

The promise of virtual care is no longer theoretical and is now a critical solution to many of healthcare’s most urgent challenges. Yet many healthcare leaders remain unsure how to build a business case for investment and launching the right program at the right time can be the difference between value and failure. For organizations seeking a financially sound, clinically effective entry point, Virtual Patient Observation (VPO) offers a compelling case to lead with.

article thumbnail

Insights from 12 Healthcare CEOs on Partnering with Performance Health Partners

Performance Health

Selecting the ideal patient safety software partner is pivotal in navigating the ever-evolving complexities of healthcare. Performance Health Partners stands out for its innovation and reliability, as confirmed by its Best in KLAS designation for two consecutive years, as well as positive feedback from numerous healthcare CEOs who have seen firsthand the significant impact of our incident management system.

More Trending

article thumbnail

Best Careers for Criminal Justice Professional Graduates

Northwest Career College

A diploma or degree in criminal justice can lead to several equally rewarding and practical career opportunities. These disciplines relate to professions associated with law enforcement and public safety. This article will identify some of the best career choices for criminal justice graduates. New field graduates may need additional education or experience to obtain these positions.

article thumbnail

GLP1a Drugs are Great But Unlikely to Treat COVID-19 Infection

Sensible Medicine

First a review of the main trial then to the new paper in the Journal of the American College of Cardiology. SELECT Trial The SELECT trial was the first to show that the glucagon-like-peptide-1 receptor agonist (GLP1) semaglutide could actually modify cardiovascular disease. The discovery of another disease-modifying agent for heart disease is a breakthrough.

Tests 309